Biogena Group Invest AG (VIE:BIO)
Austria · Delayed Price · Currency is EUR 3.100
+0.060 (1.97%)
Apr 2, 2026, 5:35 PM CET
Biogena Group Invest AG Market Cap
Biogena Group Invest AG has a market cap or net worth of €12.37 million as of April 6, 2026. Its market cap has increased by 80.23% in one year.
Market Cap
12.37M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.10
Market Cap Chart
Since November 27, 2020, Biogena Group Invest AG's market cap has increased from 7.78M to 12.37M, an increase of 58.97%. That is a compound annual growth rate of 9.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 12.37M | 3.33% |
| Dec 30, 2025 | 11.97M | 100.00% |
| Dec 30, 2024 | 5.98M | -26.47% |
| Dec 29, 2023 | 8.14M | -20.93% |
| Dec 30, 2022 | 10.29M | -12.54% |
| Dec 30, 2021 | 11.77M | 31.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wiener Privatbank SE | 53.05M |
| Linz Textil Holding AG | 51.00M |
| Wolford Aktiengesellschaft | 42.86M |
| Hutter & Schrantz Stahlbau AG | 41.57M |
| Gurktaler Aktiengesellschaft | 32.40M |
| Stadlauer Malzfabrik Aktiengesellschaft | 31.64M |
| RATH Aktiengesellschaft | 31.50M |
| Marinomed Biotech AG | 26.31M |